In vitro activity of lascufloxacin, a novel fluoroquinolone antibacterial agent, against various clinical isolates of anaerobes and Streptococcus anginosus group.

Authors :: Yamagishi Y
Matsukawa Y
Suematsu H
Mikamo H
Source :: Anaerobe [Anaerobe] 2018 Dec; Vol. 54, pp. 61-64. Date of Electronic Publication: 2018 Aug 13.
Publication Year :: 2018
Abstract: The in vitro activities of lascufloxacin were evaluated by comparison with seven reference compounds using 412 clinical isolates of anaerobes and Streptococcus anginosus group. Lascufloxacin showed potent and broad antibacterial activities greater than those of existing quinolones against the clinical isolates used in this study.<br /> (Copyright © 2018 Elsevier Ltd. All rights reserved.)

Subjects :: Bacteria, Anaerobic growth & development
Bacterial Infections microbiology
Humans
Microbial Sensitivity Tests
Streptococcal Infections microbiology
Streptococcus anginosus growth & development
Anti-Bacterial Agents pharmacology
Bacteria, Anaerobic drug effects
Fluoroquinolones pharmacology
Streptococcus anginosus drug effects

Full Text Access

Tools